ResMed (RMD) EV/EBITDA US GAAP (year values) |
|||||||||
| 2023 | 2023 | 2024 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 1.01 | 24.6 | 17.0 | 18.8 | 19.6 | 13.5 | ||
| Changes by years, y/y, % | -96% | +2 337% | -31% | +10% | +4% | -7.4% | |||
ResMed. EV/EBITDA
ResMed. EV/EBITDA, changes, %
ResMed (RMD) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | LTM ? | |||
| EV/EBITDA | ? | 18.7 | 19.5 | 19.9 | 16.8 | 15.3 | 13.5 | |
| Changes by years, y/y, % | -7% | +2% | -11% | -15% | -18% | |||
| Changes by quarters, q/q, % | -6% | +4% | +2% | -16% | -9% | |||